Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Enalapril Efficacy After Missed Dose in Hypertension
NCT00302705Phase 4Completed
- Sponsor
- Universidade de Vigo
- Start
- Jan 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of valsartan in essential hypertension (2 arms), sponsored by Universidade de Vigo. Primary endpoint: Diastolic Blood Pressure Lowering After Missing Dose at 16 weeks. Started Jan 2005; status: completed.
02
Drugs
valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00302705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302705.